Kafarov T A, Aliev N A, Aliyev Z N
Aliyev Azerbaijan State Institute of Postgraduate Medical Education, Baku, Azerbaijan Republic.
Azerbaijan Medical University Baku, Azerbaijan Republi, Azerbaijan Medical University Baku, Azerbaijan Republic.
Zh Nevrol Psikhiatr Im S S Korsakova. 2020;120(4):36-40. doi: 10.17116/jnevro202012004136.
To study alexithymia in schizophrenia and some somatic diseases.
The study included 60 patients with paranoid schizophrenia (ICD-10 F20.0), 55 hypertensive patients with primary heart disease (I11), 53 patients with chronic ischemic heart disease (I25) and 51 patients with insulin-dependent diabetes mellitus (E10). To assess the manifestations of alexithymia, the Toronto alexithymia scale (TAS-26) was used. The Positive and negative syndrome scale (PANSS) was administered to patients with schizophrenia.
The average scores on TAS were higher in patients with schizophrenia compared to patients with somatic diseases (109,73 and 81,66, respectively). During the analysis of responses to TAS statements, features of a general and particular nature were identified.
Alexithymia is not a property characteristic of psychosomatic diseases and neurotic disorders, and is detected in schizophrenic patients and patients with somatic diseases. The relationship of alexithymia with negative symptoms of schizophrenia suggests that it might impact on interpersonal relations, social adaptation and development of autistic symptoms in patients.
研究精神分裂症及某些躯体疾病中的述情障碍。
该研究纳入了60例偏执型精神分裂症患者（国际疾病分类第10版，F20.0）、55例患有原发性心脏病的高血压患者（I11）、53例慢性缺血性心脏病患者（I25）以及51例胰岛素依赖型糖尿病患者（E10）。为评估述情障碍的表现，使用了多伦多述情障碍量表（TAS - 26）。对精神分裂症患者施行了阳性与阴性症状量表（PANSS）。
与躯体疾病患者相比，精神分裂症患者的TAS平均得分更高（分别为109.73和81.66）。在分析对TAS陈述的回答过程中，识别出了一般和特殊性质的特征。
述情障碍并非心身疾病和神经症性障碍的特性，在精神分裂症患者和躯体疾病患者中均有发现。述情障碍与精神分裂症阴性症状的关系表明，它可能会影响患者的人际关系、社会适应以及自闭症症状的发展。
